1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T76673 | Bemarituzumab | FPA144 | FGFR |
Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research. |